Back to Authors

Maillis, Alex

Mayo Clinic

Mayo Clinic Florida, Clinical Research Internship Study Program, USA.

Citations 1

Medication use and polypharmacy in patients referred to a tertiary gastroenterology practice
Chris-Olaiya, Abimbola , Palmer, William C. , Lacy, Brian E. , Chirilă, Răzvan M. , Nikpour, Naveed, McLeod, Ethan, Ryan, Taylor, Maillis, Alexander , Vargas, Emily , Bouras, Ernest P., Stancampiano, Fernando, Lacy, Brian, Chirilă, Răzvan , Maillis, Alex, Bouras, Ernest, Stancampiano, Fernando F. , Heckman, Michael G.

Romanian Journal of Internal Medicine | July 10, 2020 | Volume: 58 | Issue: 4 | Pages: 228-232

10.2478/rjim-2020-0016 Get It

Abstract Introduction. Commonly prescribed medications are associated with various gastrointestinal (GI) side effects but few data are available on prescription medication use and polypharmacy in a gastroenterology outpatient practice. We aimed to examine the prevalence of polypharmacy, defined as the simultaneous use of 5 or more medications. Methods. A descriptive correlational study of consecutive outpatient consultations in 988 patients referred to a tertiary gastroenterology practice. Main outcome measurements were frequency of prescription medication use and polypharmacy. Results. The most common GI symptoms were abdominal pain (72%), nausea (57%), and constipation (53%). The frequency of polypharmacy was 10%. Eighty percent of patients took at least one medication and 60% took two or more. The most frequently used medication classes were proton pump inhibitors (43%), followed by benzodiazepines (30%), selective serotonin-reuptake or norepinephrine-reuptake inhibitors (28%), non-steroidal anti-inflammatory drugs (27%), and opioids (21%). Conclusion. There was a higher use of prescription medicine including antidepressants, and a lower frequency of polypharmacy in our study cohort compared to the general population. The use of medications may have contributed to the symptoms leading to our study’s population GI consultation.